Cardinal Health reports again on November 5, just six days after its October 30 release, and the most consequential data point heading into that print is Morgan Stanley's decision last Thursday to lift its target from $265 to $286, reaffirming Overweight at a stock price of $250. Analyst momentum has been uniformly positive for weeks. UBS raised its target to $295 on October 16…
CAH cost to borrow doubles to 0.48% in one week, highest level since late July, as shares available to borrow tighten despite minimal short interest at 2.9% of float.
Key data as of 3 Nov 2026
Three positioning signals have converged on Cardinal Health in the same week its quarterly earnings are due on October 30. Short interest climbed 10.5% in a single session on October 26, reaching 3.26% of free float,…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CAH — free to start on ORTEX.
Sign up for free →Open CAH on ORTEX